Literature DB >> 21946515

Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.

Diane Warden1, Madhukar H Trivedi, Tracy L Greer, Edward Nunes, Bruce D Grannemann, Viviana E Horigian, Eugene Somoza, Kolette Ring, Tiffany Kyle, José Szapocznik.   

Abstract

Although the selection of appropriate clinical sites has a significant impact on the successful conduct of clinical trials, no generally accepted model is available for site selection. Use of an appropriate site selection process is even more pertinent when conducting large scale, practical clinical trials in practice settings. This report provides a rationale for selecting sites by identifying both a set of basic site selection criteria important to most trials as well as criteria specific to the features of a particular study's design. In this two-tier system, although all these criteria must be met, some criteria are firm and viewed as essential for a site to conduct the trial. Other criteria, such as those that support study recruitment or participant retention, are flexible. These flexible criteria may be addressed through several alternative solutions that meet the original intent of the criterion. We illustrate how the study specific features and requirements of Stimulant Reduction Intervention using Dosed Exercise (STRIDE), a multisite clinical trial evaluating the efficacy of exercise or health education, added to treatment as usual for stimulant abuse are linked to firm and flexible site selection criteria. We also present an iterative, multi-step approach to site selection including building awareness about the study and screening and evaluating sites using these criteria. This simple model could maximize the chance that selected sites will implement a study successfully and achieve trial aims. It may be helpful to researchers who are developing criteria and methods for site selection for specific clinical trials.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946515      PMCID: PMC3253926          DOI: 10.1016/j.cct.2011.08.011

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  14 in total

1.  Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

Authors:  Lon S Schneider; M Saleem Ismail; Karen Dagerman; Sonia Davis; Jason Olin; Dennis McManus; Eric Pfeiffer; J Michael Ryan; David L Sultzer; Pierre N Tariot
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Investigator and site selection and performing GCP clinical studies in India.

Authors:  Krishan Maggon
Journal:  Control Clin Trials       Date:  2004-08

3.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 4.  Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.

Authors:  E J Topol; R M Califf; F Van de Werf; M Simoons; J Hampton; K L Lee; H White; J Simes; P W Armstrong
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

5.  Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke Prevention Study (AAASPS) experience.

Authors:  P B Gorelick; D Richardson; E Hudson; C Perry; D Robinson; N Brown; Y Harris
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

6.  The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.

Authors:  Betty Tai; Michele M Straus; David Liu; Steven Sparenborg; Ron Jackson; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2010-06

7.  The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease.

Authors:  L Mahony; L A Sleeper; P A W Anderson; W M Gersony; B W McCrindle; L L Minich; J W Newburger; J P Saul; V L Vetter; G D Pearson
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

8.  Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Elise D Cook; Sarah Moody-Thomas; Karen B Anderson; Russell Campbell; Sandra J Hamilton; Joseph M Harrington; Scott M Lippman; Lori M Minasian; Electra D Paskett; Stephen Craine; Kathryn B Arnold; Jeffrey L Probstfield
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

Review 9.  Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

Authors:  Gary S Sachs; Michael E Thase; Michael W Otto; Mark Bauer; David Miklowitz; Stephen R Wisniewski; Philip Lavori; Barry Lebowitz; Mathew Rudorfer; Ellen Frank; Andrew A Nierenberg; Maurizio Fava; Charles Bowden; Terence Ketter; Lauren Marangell; Joseph Calabrese; David Kupfer; Jerrold F Rosenbaum
Journal:  Biol Psychiatry       Date:  2003-06-01       Impact factor: 13.382

10.  Depression, IV: STAR*D treatment trial for depression.

Authors:  A John Rush; Madhukar Trivedi; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

View more
  10 in total

1.  Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.

Authors:  Tracy L Greer; Kolette M Ring; Diane Warden; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes; Madhukar H Trivedi
Journal:  J Glob Drug Policy Pract       Date:  2012

2.  Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study.

Authors:  Madhukar H Trivedi; Tracy L Greer; Chad D Rethorst; Thomas Carmody; Bruce D Grannemann; Robrina Walker; Diane Warden; Kathy Shores-Wilson; Mark Stoutenberg; Neal Oden; Meredith Silverstein; Candace Hodgkins; Lee Love; Cindy Seamans; Angela Stotts; Trey Causey; Regina P Szucs-Reed; Paul Rinaldi; Hugh Myrick; Michele Straus; David Liu; Robert Lindblad; Timothy Church; Steven N Blair; Edward V Nunes
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

3.  Comorbidities and race/ethnicity among adults with stimulant use disorders in residential treatment.

Authors:  Katherine Sanchez; Karen G Chartier; Tracy L Greer; Robrina Walker; Thomas Carmody; Chad D Rethorst; Kolette M Ring; Adriane M Dela Cruz; Madhukar H Trivedi
Journal:  J Ethn Subst Abuse       Date:  2015-01-12       Impact factor: 1.507

4.  Factors Associated With Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial.

Authors:  Bart M Demaerschalk; Robert D Brown; Gary S Roubin; Virginia J Howard; Eldina Cesko; Kevin M Barrett; Mary E Longbottom; Jenifer H Voeks; Seemant Chaturvedi; Thomas G Brott; Brajesh K Lal; James F Meschia; George Howard
Journal:  Stroke       Date:  2017-08-02       Impact factor: 7.914

5.  Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.

Authors:  Madhukar H Trivedi; Tracy L Greer; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Diane Warden; Kolette M Ring; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes
Journal:  Trials       Date:  2011-09-19       Impact factor: 2.279

6.  Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries.

Authors:  Wayne B Batchelor; Abdulla A Damluji; Celina Yong; Mona Fiuzat; Scott D Barnett; David E Kandzari; Matthew W Sherwood; Kelly C Epps; Behnam N Tehrani; Dominic J Allocco; Ian T Meredith; JoAnn Lindenfeld; Christopher M O'Connor; Roxana Mehran
Journal:  Am Heart J       Date:  2021-02-24       Impact factor: 5.099

7.  Meeting the challenges of recruitment to multicentre, community-based, lifestyle-change trials: a case study of the BeWEL trial.

Authors:  Shaun Treweek; Erna Wilkie; Angela M Craigie; Stephen Caswell; Joyce Thompson; Robert J C Steele; Martine Stead; Annie S Anderson
Journal:  Trials       Date:  2013-12-18       Impact factor: 2.279

8.  Improving site selection in clinical studies: a standardised, objective, multistep method and first experience results.

Authors:  Anahí Hurtado-Chong; Alexander Joeris; Denise Hess; Michael Blauth
Journal:  BMJ Open       Date:  2017-07-12       Impact factor: 2.692

9.  A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study.

Authors:  Thomas Carmody; Tracy L Greer; Robrina Walker; Chad D Rethorst; Madhukar H Trivedi
Journal:  Contemp Clin Trials Commun       Date:  2018-06

10.  Estimating Site Performance (ESP): can trial managers predict recruitment success at trial sites? An exploratory study.

Authors:  Hanne Bruhn; Shaun Treweek; Anne Duncan; Kirsty Shearer; Sarah Cameron; Karen Campbell; Karen Innes; Dawn McRae; Seonaidh C Cotton
Journal:  Trials       Date:  2019-04-03       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.